Savara's rare lung disease drug meets main goal in late-stage study
26/06/2024 11:39
June 26 (Reuters) - Savara SVRA.O on Wednesday said its experimental drug, molgradex, met the main goal of a late-stage trial for treating a rare lung disease characterized by a feeling of breathlessness. (Reporting by Pratik Jain in Bengaluru; Editing by Tasim Zahid) ((Pratik.Jain@thomsonreuters.com;))